Aoxin Q & M Dental Group Limited Successfully Completes Upsized Share Placement, Raises S\$20.98 Million
Key Highlights
- Completion of Upsized Placement: Aoxin Q & M Dental Group Limited has completed its previously announced Upsized Placements, issuing a total of 134,000,000 new ordinary shares.
- Fund Raising Details: The company raised an aggregate consideration of S\$20,984,400 from Q & M Dental Group (Singapore) Limited and the Placement Agent.
- Increase in Share Capital: The total number of issued shares has increased significantly from 1,023,044,096 to 1,157,044,096 (excluding treasury shares).
- Breakdown of Share Allotment:
- 50,000,000 Placement Shares allotted under the Proposed Q & M Placement
- 84,000,000 Placement Shares allotted under the Upsized SAC Placement
- Listing on SGX Catalist: The new Placement Shares are expected to be listed and quoted on the Catalist of the SGX-ST on or around 6 May 2026.
- Share Rights: The new Placement Shares will rank pari passu (equally) with all existing shares except for any dividends, rights, allotments, or other distributions where the record date falls on or before their allotment and issue date.
Details Investors and Shareholders Must Know
- Dilution of Shareholding: The issuance of 134,000,000 new shares represents a substantial increase of approximately 13.1% in the Company’s issued share capital. Existing shareholders should be aware of the potential dilution of their percentage ownership in the Company.
- Potential Impact on Share Price: Such a large placement and capital raising exercise can be price sensitive. While the injection of S\$20.98 million strengthens the Company’s financial position and may support future growth initiatives, the increased share base could exert downward pressure on the share price in the short term due to dilution.
- Dividend Entitlement: The new Placement Shares will not be entitled to any dividends, rights, allotments, or other distributions declared where the record date is before the issuance of the new shares. This is important for investors to note when considering the yield on their investments.
- Regulatory Review: The announcement has been reviewed by the Company’s sponsor, PrimePartners Corporate Finance Pte. Ltd., but has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of the announcement.
Strategic Implications
The successful completion of the Upsized Placements demonstrates the confidence of institutional investors and strategic partners, notably Q & M Dental Group (Singapore) Limited, in the future prospects of Aoxin Q & M Dental Group Limited. The injection of fresh capital provides the Company with enhanced resources to pursue growth opportunities, potentially including expansion, acquisitions, or strengthening of its balance sheet.
Shareholders should monitor the Company’s future announcements regarding the use of proceeds and any corporate developments, as these could have further implications for the Company’s valuation and share performance.
Important Dates
- Placement Completion Date: 4 May 2026
- Expected Listing Date for New Shares: On or around 6 May 2026
Contact Information
For further queries, the contact person for the Sponsor is Ms. Foo Jien Jieng, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, [email protected].
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult professional advisers before making investment decisions. The Singapore Exchange Securities Trading Limited (SGX-ST) has not reviewed or approved the content herein and assumes no responsibility for its accuracy or completeness.
View Aoxin Q & M Historical chart here
